Patent · US Active

Methods for treating colorectal cancer using prognostic genetic markers

US11180815B2 · kind B2 · utility

0Cited by

0References

2Claims

0Family size

Assignee

PACIFICEDGE LIMITED · NZ

Inventors

Hjalmar Nekarda · Essen, DE
Jan Friederichs · Hersbruck, DE
Bernhard Holzmann · Munich, DE
Robert D. Rosenberg · Brookline, US
Anthony Edmund Reeve · Dunedin, NZ
Michael Alan Black · Dunedin, NZ
John Lindsay McCall · Auckland, NZ
Yu-Hsin Lin · San Diego, US
Robert Craig Pollock · Dunedin, NZ

Key dates

Filing date	Aug 27, 2019
Grant date	Nov 23, 2021
Priority date	—
Expiry date	Aug 11, 2040

Classification

Technology area (CPC G)Physics
CPC primaryG16B25/00
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

This invention relates to prognostic signatures, and compositions and methods for determining the prognosis of cancer in a patient, particularly for colorectal cancer. Specifically, this invention relates to the use of genetic markers for the prediction of the prognosis of cancer, such as colorectal cancer based on signatures of genetic markers. In various aspects, the invention relates to a method of predicting the likelihood of long-term survival of a cancer patient, a method of determining a treatment regime for a cancer patient, a method of preparing a treatment modality for a cancer patient, among other methods as well as kits and devices for carrying out these methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.